Global Market Access & Value Strategy Leader

Xeos; Oost-Vlaanderen; Hybride; EUR 155 000 - 215 000; Plein temps

Résumé du poste

Xeos is seeking a Senior Market Access & Strategy leader to own the global market access and value strategy for our disruptive PET-CT platform. You will translate clinical and economic value into tools for hospital conversations and drive a 3–5 year evidence roadmap with Clinical Affairs and external HEOR consultants.

You will lead prioritization across US and Europe, coordinating with the CCO and commercial team, and drive measurable progress in adoption, win rates, and revenue growth.

Qualifications

• Advanced degree in health economics, public health, life sciences, medicine, or equivalent experience.
• About 10 years of experience across market access, reimbursement, HEOR, value strategy, or hospital adoption in medical devices/diagnostics.
• Proven track record in building market access or hospital adoption strategy for technology without an established reimbursement pathway.
• Deep expertise in the U.S. healthcare system: reimbursement pathways, payer landscape, IDN procurement, and GPO dynamics.
• Knowledge of CPT/HCPCS coding, coverage determinations, and payment mechanics.
• Strong understanding of hospital capital purchasing and capex processes.
• Health economics fluency: budget impact models, cost-effectiveness analyses, and value dossiers.
• Clinical literacy to engage on endpoints and evidence hierarchy with clinical teams.
• Experience directing external HEOR/market access consulting.
• Ability to translate clinical evidence into payer-relevant value claims.
• Willingness to travel to Europe and the US.
• Excellent English (written and spoken).

Responsabilités

• Own and update the market access strategy with primary focus on the U.S. and oversight of European markets via external consultants.
• Lead country and regional prioritization with the CCO based on market size, reimbursement feasibility, competition, and traction.
• Translate strategy into annual priorities, milestones, and deliverables; drive execution and adjust based on feedback.
• Define the value argumentation framework—economic, clinical, and operational—for relevant markets.
• Oversee coding, coverage, and payment strategy starting with the U.S. and define reimbursement pathways.
• Understand hospital capex cycles and GPO dynamics to support procurement.
• Collaborate with the CCO and commercial team on priority hospital accounts for access milestones.
• Drive economic evidence strategy and real-world evidence needs for 3–5 year horizon.
• Contribute to clinical study design to support market access arguments.
• Translate value stories into field-ready tools for provider conversations.
• Monitor HTA and reimbursement developments and engage stakeholders where relevant.
• Own market access execution plan with indicators and report progress to CEO.
• Represent Xeos at congresses and industry events.
• Report to our CEO.

Connaissances

Market access

HEOR

Value strategy

Hospital adoption

Stakeholder engagement

Formation

Master's or PhD in health economics, public health, life sciences, or medicine

Description du poste

Xeos is seeking a Senior Market Access & Strategy leader to own the global market access and value strategy for our disruptive PET-CT platform. You will translate clinical and economic value into tools for hospital conversations and drive a 3–5 year evidence roadmap with Clinical Affairs and external HEOR consultants.

You will lead prioritization across US and Europe, coordinating with the CCO and commercial team, and drive measurable progress in adoption, win rates, and revenue growth.